DekaBank Deutsche Girozentrale boosted its position in shares of CVS Health Corporation (NYSE:CVS) by 4.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 393,629 shares of the pharmacy operator’s stock after buying an additional 16,525 shares during the period. DekaBank Deutsche Girozentrale’s holdings in CVS Health Corporation were worth $31,093,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in CVS. Hunter Associates Investment Management LLC increased its stake in shares of CVS Health Corporation by 7.3% in the fourth quarter. Hunter Associates Investment Management LLC now owns 3,680 shares of the pharmacy operator’s stock worth $290,000 after buying an additional 250 shares in the last quarter. Hemenway Trust Co LLC increased its stake in shares of CVS Health Corporation by 0.4% in the fourth quarter. Hemenway Trust Co LLC now owns 148,350 shares of the pharmacy operator’s stock worth $11,706,000 after buying an additional 651 shares in the last quarter. Coho Partners Ltd. increased its stake in shares of CVS Health Corporation by 1.3% in the fourth quarter. Coho Partners Ltd. now owns 1,444,370 shares of the pharmacy operator’s stock worth $113,975,000 after buying an additional 18,697 shares in the last quarter. Frontier Wealth Management LLC increased its stake in shares of CVS Health Corporation by 68.9% in the fourth quarter. Frontier Wealth Management LLC now owns 26,387 shares of the pharmacy operator’s stock worth $2,082,000 after buying an additional 10,764 shares in the last quarter. Finally, Marshall Wace LLP increased its stake in shares of CVS Health Corporation by 652.2% in the fourth quarter. Marshall Wace LLP now owns 504,781 shares of the pharmacy operator’s stock worth $39,833,000 after buying an additional 437,676 shares in the last quarter. Institutional investors own 82.05% of the company’s stock.

Shares of CVS Health Corporation (CVS) traded down 1.44% during mid-day trading on Thursday, hitting $78.60. 5,055,217 shares of the stock were exchanged. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $98.44. The firm has a market cap of $80.08 billion, a P/E ratio of 16.41 and a beta of 0.91. The stock’s 50 day moving average is $78.75 and its 200 day moving average is $79.09.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.07. The business had revenue of $44.51 billion during the quarter, compared to the consensus estimate of $44.20 billion. CVS Health Corporation had a return on equity of 17.56% and a net margin of 2.86%. The company’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the company earned $1.18 earnings per share. Analysts expect that CVS Health Corporation will post $5.87 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.54%. The ex-dividend date of this dividend is Thursday, July 20th. CVS Health Corporation’s dividend payout ratio is presently 41.67%.

TRADEMARK VIOLATION WARNING: “DekaBank Deutsche Girozentrale Buys 16,525 Shares of CVS Health Corporation (CVS)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/08/03/dekabank-deutsche-girozentrale-boosts-position-in-cvs-health-corporation-cvs-updated-updated-updated.html.

CVS has been the topic of a number of recent analyst reports. Vetr raised shares of CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 target price on the stock in a research note on Wednesday, May 24th. Tigress Financial started coverage on shares of CVS Health Corporation in a research note on Thursday, April 27th. They set a “buy” rating on the stock. Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a research note on Tuesday, June 27th. Guggenheim reissued a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Finally, Needham & Company LLC started coverage on shares of CVS Health Corporation in a research note on Tuesday, June 27th. They set a “hold” rating on the stock. Ten analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $93.67.

In other news, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $80.00, for a total value of $18,440,800.00. Following the completion of the transaction, the chief financial officer now directly owns 176,983 shares in the company, valued at $14,158,640. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Helena Foulkes sold 20,333 shares of the firm’s stock in a transaction dated Monday, June 26th. The stock was sold at an average price of $80.00, for a total value of $1,626,640.00. Following the completion of the transaction, the executive vice president now owns 59,301 shares of the company’s stock, valued at $4,744,080. The disclosure for this sale can be found here. In the last three months, insiders sold 271,175 shares of company stock valued at $21,632,597. Corporate insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.